Plain-English translation of NCT07039617 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing AIDANET, a new automated insulin delivery system designed to help people with type 1 diabetes manage their blood sugar with less manual input. The study compares two different ways of using the system: one where you announce your meals before eating, and one where the system works entirely on its own without meal announcements. Researchers want to see which approach works best for people's daily life.
Current insulin delivery systems require people to manually announce meals and calculate insulin doses, which can be burdensome and error-prone. This trial is testing whether a system that can work completely automatically—or with simpler meal announcements—might make blood sugar management easier and safer for people with type 1 diabetes.
You likely qualify if…
You likely don't qualify if…
You will participate in four separate four-week phases over about four months. In two phases, you'll test the AIDANET system in different modes (one where you announce meals, one where you don't), and in a third phase you can use whichever mode you prefer. You'll also spend one four-week period using a standard insulin delivery system so researchers can compare the results. Throughout the study, you'll wear a continuous glucose monitor, upload your data regularly, and attend in-person training sessions.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States